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Objectives. To study the interaction of polymorphic markers for matrix metalloproteinases (MMP) and 
chronic stress on formation of stroke on the background of hypertensive disease. Materials and methods. 
A total of 830 patients were studied: 303 patients with ischemic stroke on the background of hypertensive 
disease and 527 patients with hypertensive disease without stroke. SNP for metalloproteinases were stud-
ied using the real-time polymerase chain reaction. The functional signifi cance and infl uences of polymor-
phic loci on gene expression were studied using the HaploReg (v4.1) (http://archive.broadinstitute.org) and 
GTEx-portal (http://gtexportal.org) services. Results and conclusions. An association was found between 
the GG rs11568818 genotype of the MMP7 gene and a high risk of developing stroke in patients experi-
encing regular stress (odds ratio (OR) 1.71). The 5A allele and the 5A/5A genotype of rs3025058 of the 
MMP3 gene had protective effects on development of stroke in people without histories of chronic stress 
(OR 0.73 and OR 0.60, respectively). The SNP studied here were located in the histone protein H3K4me1 
and H3K4me3 region, which is hypersensitive to DNase 1 and binds regulatory proteins and transcription 
factors, while the polymorphic rs11568818 locus is linked with the level of expression of the MMP7 gene.
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 More than 400,000 cases of stroke are recorded in the 
Russian Federation each year, with death from cerebrovas-
cular diseases being the highest among the European states 
[1]. Ischemic stroke is an acute impairment to cerebral blood 
fl ow, is accompanied by brain tissue hypoxia and necrosis, 
and leads to neurological defi cit [2]. Stroke involves trig-
gering of a cascade of neuroinfl ammatory reactions, the key 
element of which is release of matrix metalloproteinases 
(MMP), which are responsible for degrading components of 
the extracellular matrix [3]. Previous studies showed that the 
level of expression of MMP genes correlates with the devel-
opment of cerebral stroke [4]. Along with genetic factors, 
environmental factors are also involved in the occurrence of 
stroke; among these, an important role is played by chronic 
emotional stress [5, 6]. Epidemiological studies show that 
long-lasting psychoemotional tension leads to changes in the 
biochemical composition and electrolyte composition of the 
blood, thrombus formation, and suppression of the immune 
system [6, 7]. The aim of the present work was to study the 
role of chronic stress in realizing the genetic predisposition 
to stroke on the background of hypertensive disease (HTD).
 Materials and methods. Results from investigation of 
830 patients were analyzed: group 1 consisted of 303 patients 
with ischemic stroke on the background of HTD; group 2 con-
sisted of 527 patients with HTD without any history of impair-
ment to the cerebral circulation. Groups were formed in the 
period from 2013 to 2016 in the Departments of Neurology 
and Cardiology, St. Joseph Belgorod District Clinical Hospital 
(BDCH). Among stroke patients, the atherothrombotic sub-
type was seen in 124 patients (40.93%), the cardioembol-
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taking part in the study, along with total cholesterol (TCH), 
high-density lipoprotein cholesterol (HDL CH), low-density 
lipoprotein cholesterol (LDL CH), and triglycerides (TG). 
Blood samples for biochemical analysis were collected after 
8-h starvation; analyses were run at the St. Joseph BDCH. All 
respondents assessed the presence of chronic stressors which, 
according to [10], included the following psychosocial fac-
tors: frequent stressful situations at home and/or at work, the 
absence of social support, family situation (single, separated, 
widowed), unsatisfactory social-economic status.
 The characteristics of the study groups are given in 
Tables 1 and 2. There were no differences in age and sex 
composition, BMI, levels of TCH and LDL CH between 
patients of groups 1 and 2, or levels of stress experienced, 
though there were signifi cant differences in BP, TG, and 
HDL CH (p < 0.05).
ic in 72 patients (23.76%), the hemodynamic in 78 patients 
(25.74%), and the lacunar in 29 patients (9.57%). There were 
no patients with arterioarterial emboli or strokes of the hemor-
heological microocclusion type. The study cohort consisted of 
unrelated people of Russian nationality, natives of the Russian 
Central Chernozem [8]. Inclusion criteria for the groups 
analyzed were a systolic arterial blood pressure (BP) ≥ 140 
mmHg and/or diastolic BP ≥ 90 mmHg, and use by patients of 
antihypertensive drugs; exclusion criteria were the presence 
of symptomatic and secondary hypertension, kidney or liv-
er failure, and refusal to take part in the study. The diagnosis 
“ischemic stroke” was made on the basis of data on neurolog-
ical status, the patient’s complaints, and brain CT/MRI scans. 
HTD was diagnosed in accordance with the diagnostic criteria 
of the All-Russian Scientifi c Cardiology Society [9]. Body 
mass index (BMI, kg/m2) was determined for all subjects 
TABLE 1. Clinical Characteristics of Study Groups of Patients
Parameter Group 1 (n = 303) Group 2 (n = 527) p
Men/women, abs. (%) 201/102 (66.34/33.66) 322/205 (61.11/38.89) 0.15
Mean age, years 59.58 ± 8.21 58.81 ± 7.74 0.85
BMI, kg/m2 30.64 ± 5.63 31.05 ± 4.43 0.09
Systolic BP, mmHg 190.73 ± 24.21 176.04 ± 16.28 0.001
Diastolic BP, mmHg 108.53 ± 13.42 103.83 ± 9.12 0.001
TCH, mM 5.73 ± 1.13 5.74 ± 1.07 0.92
HDL CH, mM 1.28 ± 0.31 1.38 ± 0.42 0.001
LDL CH, mM 3.76 ± 1.06 3.81 ± 0.73 0.35
TG, mM 1.83 ± 1.14 2.05 ± 0.65 0.001
Presence of chronic stressors, abs. (%) 103 (33.99) 187 (35.48) 0.72
TABLE 2. Clinical Characteristics of Groups Stratifi ed by Presence of Chronic Stressors
Parameter
Presence of chronic stressors Absence of chronic stressors
Group 1 (n = 103) Group 2 (n = 187) p Group 1 (n = 200) Group 2 (n = 340) p
Men/women, abs. (%) 58/45 (56.31/43.69) 105/82 (56.15/43.85) 0.99 143/57 (71.50/28.50) 217/123 (63.82/36.18) 0.08
BMI, kg/m2 31.74 ± 5.59 31.46 ± 4.98 0.98 29.99 ± 4.36 30.79 ± 5.11 0.65
Age, years 60.11 ± 7.42 59.07 ± 8.64 0.18 59.30 ± 8.01 58.74 ± 7.68 0.38
Systolic BP, mmHg 193.05 ± 22.27 177.06 ± 13.31 0.001 189.54 ± 19.13 175.43 ± 13.56 0.001
Diastolic BP, mmHg 111.26 ± 17.44 104.15 ± 9.65 0.001 107.13 ± 15.67 103.64 ± 10.02 0.002
TCH, mM 6.63 ± 1.42 6.28 ± 1.88 0.71 5.74 ± 1.33 5.69 ± 1.49 0.65
HDL CH, mM 1.98 ± 0.86 1.88 ± 0.56 0.74 1.77 ± 0.67 1.67 ± 0.61 0.86
LDL CH, mM 4.69 ± 1.63 4.28 ± 0.97 0.53 3.77 ± 1.01 3.82 ± 0.74 0.77
TG, mM 2.85 ± 1.14 2.65 ± 0.83 0.66 3.31 ± 1.00 2.29 ± 0.96 0.97
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pression (as per the HaploReg (v. 4.1) database at http://ar-
chive.broadinstitute.org).
 Venous blood (5-ml samples) was collected from 
the median cubital vein into plastic Vacutainer tubes with 
EDTA. Genomic DNA was extracted from peripheral blood 
leukocytes using a standard phenol-chloroform procedure. 
Polymorphisms were analyzed using the polymerase chain 
reaction (real-time PCR) on a CFX-96 real-Time System 
thermal cycler (Bio-Rad, USA) using oligonucleotide prim-
ers and probes synthesized at the Sintol Company. The 
nucleotide sequences of primers and probes are given by 
Lievre et al. and Pradhan-Palikhe et al. [12, 13]. Repeat ge-
notyping of 5% of samples selected at random from patients 
of the study group demonstrated 100% reproducibility.
 In both groups of patients – those subjected to stress 
and those not experiencing chronic stress – patients with 
stroke on the background of HTD and with HTD but not 
stroke were comparable in terms of sex, age, BMI, and lipid 
profi le (p > 0.05). Study patients in both groups were sig-
nifi cantly different in terms of BP (p < 0.05).
 Genetic analysis. All patients were genotyped at eight 
polymorphic loci: rs1799750 of MMP1, rs243865 of MMP2, 
rs3025058 of MMP3, rs11568818 of MMP7, rs1320632 
of MMP8, rs11225395 of MMP8, rs17577 of MMP9, and 
rs652438 of MMP12. Study polymorphisms were selected 
on the basis of previously described criteria [11]. All poly-
morphic markers selected for study were characterized by 
signifi cant regulatory potential and infl uences on gene ex-
TABLE 3. Distribution of Polymorphic MMP Genotype Markers in the Study Groups
Locus Genotype
Group 1 (n = 303) Group 2 (n = 527)
OR (95% CI) p
abs. (%)
rs11568818 MMP7
AA (ref) 113 (38.17) 179 (34.16) 1.00 (ref) –
AG 143 (48.31) 258 (49.24) 0.88 (0.63–1.21) 0.46
GG 40 (13.52) 87 (16.60) 0.73 (0.46–1.16) 0.19
rs1320632 MMP8
AA (ref) 245 (82.49) 441 (84.64) 1.00 (ref) –
AG 48 (16.16) 76 (14.59) 1.14 (0.75–1.72) 0.59
GG 4 (1.35) 4 (0.77) 1.80 (0.38–3.62) 0.64
rs11225395 MMP8
CC (ref) 97 (32.12) 163 (30.99) 1.00 (ref) –
CT 146 (48.34) 258 (49.05) 0.95 (0.68–1.33) 0.82
TT 59 (19.54) 105 (19.96) 0.94 (0.62–1.44) 0.86
rs1799750 MMP1
1G/1G (ref) 85 (28.06) 153 (29.03) 1.00 (ref) –
1G/2G 146 (48.18) 258 (48.96) 1.02 (0.72–1.44) 0.98
2G/2G 72 (23.76) 116 (22.01) 1.12 (0.74–1.69) 0.65
rs3025058 MMP3
6А/6А (ref) 101 (33.33) 149 (28.38) 1.00 (ref) –
5А/6А 148 (48.85) 263 (50.10) 0.83 (0.59–1.16) 0.30
5А/5А 54 (17.82) 113 (21.52) 0.71 (0.46–1.08) 0.12
rs652438 MMP12
AA (ref) 259 (85.76) 460 (87.45) 1.00 (ref) –
AG 41 (13.58) 63 (11.98) 1.16 (0.74–1.80) 0.57
GG 2 (0.66) 3 (0.57) 1.18 (0.14–1.73) 0.99
rs243865 MMP2
CC (ref) 170 (56.11) 311 (59.01) 1.00 (ref) –
CT 109 (35.97) 184 (34.92) 1.08 (0.79–1.48) 0.65
TT 24 (7.92) 32 (6.07) 1.37 (0.75–2.49) 0.33
rs17577 MMP9
GG (ref) 200 (67.12) 352 (67.30) 1.00 (ref) –
AG 90 (30.20) 155 (29.64) 1.02 (0.73–1.41) 0.95
AA 8 (2.68) 16 (3.06) 0.88 (0.34–2.22) 0.94
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ment interactions seen here for polymorphic MMP loci and 
chronic stressors on formation of stoke may be due to the 
ability of matrix metalloproteinases to carry out the proteo-
lytic cleavage of cell adhesion molecules, which modulate 
neuron plasticity and play a key role in stress-induced ad-
aptations [16]. The important modifying infl uence of the 
stress factor on development of ischemic stroke has also 
been demonstrated in other studies. The results of six cohort 
studies (total 138,782 participants) were used to analyze a 
group of scientists in the People’s Republic of China; this 
provided evidence that regular stress at work is associated 
with a high risk of developing ischemic stroke (OR 1.58, 
95% CI 1.12–2.23) [5]. Published data indicate that chronic 
stress induces impairments to the operation of the hypothal-
amo-hypophyseal-adrenal axis and imbalance in sympa-
thetic and parasympathetic regulation, which leads to the 
development of cerebrovascular pathology [7].
 Analysis of the functional signifi cance of polymorphic 
loci associated with stroke showed that the rs11568818 
SNP of the MMP7 gene is located in an area hypersensi-
tive to DNase 1 in endotheliocytes, neuroglia, hematopoi-
etic stem cells, fi broblasts, and normal and pathologically 
altered epithelial cells. This locus relates to the binding site 
for modifi ed histone proteins (H3K4me1 and H3K4me3), 
which mark promoters in four tissues (including hemato-
poietic and mesenchymal stem cells, astrocytes, and neuron 
precursors) and enhancers in seven tissues (including the 
substantia nigra, caudate nucleus, and hippocampus). The 
rs11568818 SNP is located in the region attaching regula-
tory proteins with c-Fos, c-Jun, and TBP, and is also pres-
ent in regulatory DNA motifs binding four transcription 
factors. The G gene variants at this locus, which is asso-
ciated with a high risk of developing stroke, increases af-
fi nity for the transcription factors Foxa known-1 (ΔLOD 
score –3.1), PLZF (ΔLOD score –1.5), and Pou5fl  known-2 
(ΔLOD score –3.2) and decreases affi nity for GR known4 
(ΔLOD score 0.8) (https://pubs.broadinstitute.org). In silico 
analysis established that the “risky” G allele of the MMP7 
rs11568818 locus is associated with a decrease in the lev-
el of expression of the corresponding gene in the pancreas 
(β = –0.31, p = 5.1·10–11, FDR ≤ 0.05), lungs (β = –0.35, 
p = 8.1·10–14, FDR ≤ 0.05), skin (β = –0.23, p = 3.9·10–8, 
FDR ≤ 0.05), stomach (β = –0.32, p = 1.9·10–6, FDR ≤ 0.05), 
and liver (β = –0.46, p = 1.2·10–5, FDR ≤ 0.05). According 
to the GeneCards database, the MMP7 gene is located on 
chromosome 11 and encodes a proteolytic enzyme cleav-
ing elastin, types I, III, IV, and V gelatin, and fi bronectin. 
MMP7 proteinase is involved in remodeling the extracellu-
lar matrix, cell proliferation, and regeneration of damaged 
tissues, and supports cell migration and apoptosis (http://
www.genecards.org/). The epigenetic effects of the poly-
morphic locus of the MMP7 gene and the function of the 
corresponding peptidase may underlie the known asso-
ciation with formation of ischemic stroke. The literature 
available to us contained of association studies addressing 
 Assessment of the functional signifi cance of polymor-
phisms. The regulatory potential of SNP was determined 
using the online HaploReg (v4.1) (https://pubs.broadinsti-
tute.org) service. Associations of polymorphic alleles with 
the affi nity of the DNA motif for transcription factors were 
assessed in terms of differences between LOD scores for the 
alternative (alt) and reference (ref) alleles [14]. The effects 
of SNP on the expression of genes (cis-eQTL) were analyzed 
using data from the Genotype-Tissue Expression project 
(GTEx) (http://www.gtexportal.org). Associations between 
alleles and levels of gene transcription were determined us-
ing the linear regression β coeffi cient, which characterizes 
changes in the normalized measures of gene expression on 
a single alt allele. Results with p < 8·10 –5, pFDR ≤ 0.05 were 
used [15].
 The study was approved by the Ethics Committee of 
the medical institute of Belgorod National State Research 
University; informed consent was obtained from all subjects.
 Statistical analysis. Correspondence of genotype fre-
quencies with the Hardy–Weinberg equilibrium was as-
sessed using the χ2 test. Allele and genotype frequencies 
in groups of patients with stroke and without stroke were 
analyzed using 2 × 2 linkage tables and the χ2 test with the 
Yates correction for continuity. Calculations were run in 
Statistica for Windows 10.0. The nature of associations be-
tween SNP and stress with formation of stroke on the back-
ground of HTD was assessed using the odds ratio (OR) and 
its 95% confi dence interval (95% CI), and differences were 
regarded as signifi cant at p < 0.05.
 Results and discussion. Distributions of allele and 
genotype frequencies in groups 1 and 2 for all the polymor-
phisms studied corresponded to the Hardy–Weinberg equi-
librium (p > 0.05). The analysis results are presented in 
Table 3; there were no signifi cant differences between study 
groups (p > 0.05).
 Results from analysis of the interaction between MMP 
and chronic stresses on formation of ischemic stroke on the 
background of GP are shown in Table 4.
 It is of note that formation of stroke on the background 
of HTD in people subjected to stress and patients not ex-
posed to chronic stresses involved several polymorphic 
MMP loci. Among patients with ischemic stroke and sub-
jected to regular stress, the frequency of GG homozygotes 
at the MMP7 rs11568818 locus was signifi cantly greater 
(χ2 = 3.89, p = 0.04) than in the group of patients with HTD 
without stroke. Thus, the G allele of rs11568818 increased 
the risk of developing stroke in patients with HTD and ex-
posed to stress (OR 1.71, 95% CI 1.00–2.92). In the group 
of patients with HTD not exposed to chronic stress, the fre-
quencies of the 5A allele (χ2 = 5.43; p = 0.02) and the 5A/5A 
genotype (χ2 = 4.34; p = 0.04) at the MMP3 rs3025058 
locus were signifi cantly higher than among patients with 
stroke. These genetic variants had protective infl uences on 
formation of ischemic stroke on the background of HTD 
(OR 0.73 and OR 0.60, respectively). The gene-environ-
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TABLE 4. Comparative Analysis of MMP Polymorphism Allele and Genotype Frequencies Stratifi ed for the Presence of Stress
Locus Allele, genotype
Presence of chronic stressors Absence of chronic stressors
Group 1, abs. (%) 
(n = 103)
Group 2, abs. (%) 
(n = 187) OR (95% CI) p
Group 1, abs. (%) 
(n = 200)
Group 2, abs. (%) 
(n = 340) OR (95% CI) p
MMР1
rs1799750
1G 110 (53.40) 197 (52.67) 1.03 (0.72–1.47) 0.93 206 (51.50) 367 (53.97) 0.91 (0.70–1.16) 0.47
2G 96 (46.60) 177 (47.33) 0.97 (0.68–1.39) 194 (48.50) 313 (46.03) 1.10 (0.86–1.43)
1G/1G 32 (31.07) 58 (31.02) 1.01 (0.57–1.74) 0.99 53 (26.50) 95 (27.94) 0.93 (0.61–1.40) 0.79
1G/2G 46 (44.66) 81 (43.31) 1.05 (0.63–1.76) 0.92 100 (50.00) 177 (52.06) 0.92 (0.64–1.33) 0.71
2G/2G 25 (24.27) 48 (25.67) 0.93 (0.51–1.68) 0.90 47 (23.50) 68 (20.00) 1.23 (0.79–1.91) 0.39
MMР2
rs243865
С 156 (75.73) 281 (75.13) 1.03 (0.68–1.56) 0.95 293 (73.25) 525 (77.21) 0.80 (0.60–1.09) 0.16
T 50 (24.27) 93 (24.87) 0.97 (0.64–1.46) 107 (26.75) 155 (22.79) 1.24 (0.92–1.66)
СС 61 (59.22) 106 (56.68) 1.11 (0.66–1.86) 0.77 109 (54.50) 205 (60.29) 0.79 (0.55–1.14) 0.22
СT 34 (33.01) 69 (36.90) 0.84 (0.49–1.44) 0.59 75 (37.50) 115 (33.83) 1.17 (0.80–1.72) 0.44
TT 8 (7.77) 12 (6.42) 1.22 (0.44–3.37) 0.85 16 (8.00) 20 (5.88) 1.39 (0.67–2.88) 0.44
MMР3
rs3025058
5А 92 (44.66) 161 (43.04) 1.06 (0.74–1.52) 0.77 164 (41.00) 328 (48.52) 0.73 (0.57–0.95) 0.02
6А 114 (55.34) 213 (56.95) 0.94 (0.65–1.34) 236 (59.00) 348 (51.48) 1.36 (1.05–1.75)
5А/5А 22 (21.36) 32 (17.11) 1.31 (0.69–2.51) 0.46 32 (16.00) 81 (23.97) 0.60 (0.37–0.97) 0.04
5А/6А 48 (46.60) 97 (51.87) 0.81 (0.48–1.34) 0.46 100 (50.00) 166 (49.11) 1.04 (0.72–1.49) 0.91
6А/6А 33 (32.04) 58 (31.02) 1.05 (0.60–1.82) 0.96 68 (34.00) 91 (26.92) 1.39 (0.94–2.08) 0.10
MMР7
rs11568818
А 64 (32.65) 152 (40.86) 0.70 (0.48–1.02) 0.07 145 (36.62) 282 (41.71) 0.81 (0.62–1.05) 0.11
G 132 (67.35) 220 (59.14) 1.42 (0.97–2.08) 251 (63.38) 394 (58.29) 1.24 (0.95–1.61)
АА 10 (10.20) 26 (13.98) 0.70 (0.29–1.60) 0.47 23 (11.62) 61 (18.05) 0.60 (0.34–1.03) 0.06
АG 44 (44.90) 100 (53.76) 0.70 (0.42–1.18) 0.19 99 (50.00) 160 (47.34) 1.11 (0.77–1.60) 0.61
GG 44 (44.90) 60 (32.26) 1.71 (1.00–2.92) 0.04 76 (38.38) 117 (34.61) 1.17 (0.80–1.72) 0.43
ММР8
rs1320632
А 178 (89.00) 342 (92.43) 0.66 (0.35–1.24) 0.22 360 (90.91) 616 (91.67) 0.91 (0.57–1.44) 0.75
G 22 (11.00) 28 (7.57) 1.51 (0.80–2.81) 36 (9.09) 56 (8.33) 1.10 (0.69–1.74)
АА 80 (80) 159 (85.94) 0.65 (0.32–1.30) 0.26 165 (83.33) 282 (83.93) 0.96 (0.58–1.58) 0.95
АG 18 (18) 24 (12.98) 1.47 (0.72–3.01) 0.33 30 (15.15) 52 (15.48) 0.97 (0.58–1.63) 0.99
GG 2 (2) 2 (1.08) 1.87 (0.18–3.90) 0.92 3 (1.52) 2 (0.59) 2.57 (0.34–2.09) 0.55
MMР8
rs11225395
С 113 (54.85) 205 (54.81) 1.00 (0.70–1.43) 0.99 227 (57.04) 379 (55.90) 1.05 (0.81–1.35) 0.76
Т 93 (45.15) 169 (45.19) 0.99 (0.69–1.42) 171 (42.96) 299 (44.10) 0.95 (0.74–1.24)
СС 27 (26.22) 59 (31.55) 0.77 (0.43–1.36) 0.41 70 (35.17) 104 (30.68) 1.23 (0.83–1.81) 0.32
СТ 59 (57.28) 87 (46.52) 1.54 (0.92–2.58) 0.10 87 (43.72) 171 (50.44) 0.76 (0.53–1.10) 0.15
ТТ 17 (16.50) 41 (21.93) 0.70 (0.35–1.37) 0.34 42 (21.11) 64 (18.88) 1.15 (0.73–1.82) 0.61
MMР9
rs17577
G 164 (82.83) 311 (84.51) 0.88 (0.54–1.44) 0.16 326 (81.91) 548 (80.83) 1.07 (0.77–1.50) 0.72
А 34 (17.17) 57 (15.49) 1.13 (0.69–1.84) 72 (18.09) 130 (19.17) 0.93 (0.67–1.30)
GG 66 (66.67) 133 (72.28) 0.76 (0.44–1.35) 0.39 134 (67.34) 219 (64.60) 1.13 (0.77–1.66) 0.58
GА 32 (32.32) 45 (24.46) 1.47 (0.83–2.62) 0.20 58 (29.14) 110 (32.45) 0.86 (0.57–1.28) 0.48
АА 1 (1.01) 6 (3.26) 0.30 (0.01–2.58) 0.45 7 (3.52) 10 (2.95) 1.20 (0.40–3.48) 0.91
MMР12
rs652438
А 189 (91.75) 353 (94.39) 0.66 (0.32–1.35) 0.29 370 (92.50) 630 (92.65) 0.98 (0.60–1.61) 0.99
G 17 (8.25) 21 (5.61) 1.51 (0.74–3.07) 30 (7.50) 50 (7.35) 1.02 (0.62–1.67)
АА 87 (84.47) 167 (89.31) 0.65 (0.30–1.40) 0.31 172 (86.00) 293 (86.18) 0.98 (0.58–1.68) 0.99
АG 15 (14.56) 19 (10.16) 1.51 (0.69–3.29) 0.36 26 (13.00) 44 (12.94) 1.01 (0.58–1.74) 0.99
GG 1 (0.97) 1 (0.53) 1.82 (0.05–7.04) 0.99 2 (1.00) 3 (0.88) 1.13 (0.13–8.40) 0.99
Signifi cant differences are shown in bold.
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analysis of the involvement of the rs11568818 SNP and the 
development of ischemic stroke, though there are reports of 
associations between this locus and cardiovascular patholo-
gy in people living in Sweden [17].
 The rs3025058 single-nucleotide polymorphism of the 
MMP3 gene is indicated by HaploReg (ver4.1) to be locat-
ed in the region of histone H3K4me1, which encodes en-
hancers in mesenchymal cells and epitheliocytes. This locus 
is located in an area hypersensitive to DNase 1 in the thymus 
and in the area of regulatory DNA motifs binding two tran-
scription factors. The 6A allele has been found to decrease 
affi nity for transcription factors Ciz (ΔLOD score 1.3) and 
Gfi -1b (ΔLOD score 1.7). According to the GeneCards da-
tabase, he MMP3 gene encodes enzyme MMP3, which is 
able to hydrolyze fi bronectin, laminin, proteoglycans, col-
lagens, and types I–V gelatin (http://www.genecards.org/). 
The level of MMP3 expression is regulated by cytokines 
and growth factors and is increased in atherogenesis, on-
cogenesis, and post-injury tissue regeneration. The results 
obtained here are consistent with data from other associa-
tion studies: Sherva et al. [18] found that Americans with 
the 5A/5A genotype at the rs3025058 locus of the MMP3 
gene have a signifi cantly lower risk of developing ischemic 
stroke than carriers of the 5A/6A and 6A/6A genotypes 
(OR 0.51, 95% CI 0.31–0.85, p = 0.01).
 Thus, the results of the studies reported here provide 
evidence for the signifi cant role of the interaction of poly-
morphic MMP loci with stress in the formation of ischemic 
stroke on the background of HTD. Risk factors for disease 
development in patients subjected to chronic stressors are 
the rs11568818 GG genotype of the MMP7 gene (OR 1.71). 
The 5A allele has protective value in relation to the devel-
opment of stroke in people not subjected to chronic stress-
ors (OR 0.73), as does the 5A/5A genotype (OR 0.60) of 
the rs3025058 polymorphism of the MMP3 gene. These 
polymorphic loci are characterized by signifi cant regulatory 
potential (they are located in the area of histones marking 
promoters and enhancers in cell cultures, neuron precursors, 
mesenchymal cells, etc., and the area containing regulato-
ry DNA motifs and binding sites for transcription factors), 
while the rs11568818 SNP is linked with the level of ex-
pression of the MMP7 gene in the liver, lungs, pancreas, and 
other organs.
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